JPMorgan Chase & Co. Has $55,000 Holdings in Cellectar Biosciences, Inc. (NASDAQ:CLRB)
JPMorgan Chase & Co. lifted its position in shares of Cellectar Biosciences, Inc. (NASDAQ:CLRB – Free Report) by 687.3% during the 4th quarter, HoldingsChannel reports. The fund owned 182,403 shares of the biopharmaceutical company’s stock after purchasing an additional 159,234 shares during the period. JPMorgan Chase & Co.’s holdings in Cellectar Biosciences were worth $55,000 […]
JPMorgan Chase & Co. lifted its position in shares of Cellectar Biosciences, Inc. (NASDAQ:CLRB – Free Report) by 687.3% during the 4th quarter, HoldingsChannel reports. The fund owned 182,403 shares of the biopharmaceutical company’s stock after purchasing an additional 159,234 shares during the period. JPMorgan Chase & Co.’s holdings in Cellectar Biosciences were worth $55,000 […]
